Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)
Journal of Allergy and Clinical Immunology: Global（2022）
摘要
This phase 3 study will provide important information on the potential of omalizumab to treat patients with multiple food allergies.
更多查看译文
关键词
Food allergy,immunotherapy,immunomodulator,omalizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要